Collectively, these data strongly suggested that LHXI-DT was required for the proliferation of BC cells in vitro and targeting LHX1-DT could inhibit tumorigenesis and tumor growth of BC cells in vivo. This evidence concerns the gene LHX1 and neoplasm.